Literature DB >> 29927796

IMPROVED DETECTION AND DIAGNOSIS OF POLYPOIDAL CHOROIDAL VASCULOPATHY USING A COMBINATION OF OPTICAL COHERENCE TOMOGRAPHY AND OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY.

Chui Ming Gemmy Cheung1, Yasuo Yanagi1, Masahiro Akiba2, Anna Tan1, Ranjana Mathur1, Choi Mun Chan1, Ian Yeo1, Tien Y Wong1.   

Abstract

PURPOSE: To assess the ability of optical coherence tomography (OCT) alone and in combination with OCT angiography (OCTA) to differentiate polypoidal choroidal vasculopathy (PCV) from neovascular age-related macular degeneration, as compared to fluorescein angiography and indocyanine green angiography.
METHODS: This is a cross-sectional study. All participants had a standardized history, clinical examination including measurement of best-corrected visual acuity, slit-lamp biomicroscopy, and indirect fundus examination, and underwent standardized imaging (color photography, fluorescein and indocyanine green angiography, OCT, and OCTA) after predefined protocols. We used a 2-step approach (Step 1: spectral domain OCT; Step 2: addition of OCTA) combining structural OCT and OCTA to differentiate 50 treatment-naive eyes with PCV, choroidal neovascularization, and retinal angiomatous proliferation and compared with the diagnosis based on fluorescein angiography and indocyanine green angiography. Spectral domain OCT signs used to diagnose PCV included presence of two out of three of any retinal pigment epithelium detachment (pigment epithelial detachment/double-layer sign), notched or narrow-peaked pigment epithelial detachment, or round subretinal pigment epithelium structure. Optical coherence tomography angiography signs used to diagnose PCV included presence of a localized subretinal pigment epithelium hyperflow signal in the cross-sectional OCTA and/or presence of a focal hyperflow sign in en face OCTA based on outer retina slab.
RESULTS: Based on fluorescein angiography and indocyanine green angiography, the diagnosis was choroidal neovascularization in 24 eyes, PCV in 23 eyes, and retinal angiomatous proliferation in 3 eyes. Based on spectral domain OCT signs, PCV was diagnosed in 19/23 (82.6%) eyes; however, specificity of OCT was only 51.9%. Cross-sectional OCTA showed a diffuse hyperflow signal in all 24 (100.0%) eyes with choroidal neovascularization, whereas a localized subretinal pigment epithelium hyperflow signal was detected in 19/23 (82.6%) eyes with PCV. En face OCTA only detected a nodular hyperflow signal in 10/23 eyes (43.5%) with PCV. Combination of OCT and OCTA achieved 82.6% sensitivity and 100.0% specificity for differentiating PCV from choroidal neovascularization/retinal angiomatous proliferation.
CONCLUSION: Cross-sectional OCTA is more sensitive than en face OCTA in detecting flow signal in polyps. Combination of structural OCT and OCTA can be used to screen for PCV with a high level of sensitivity and specificity.

Entities:  

Year:  2019        PMID: 29927796     DOI: 10.1097/IAE.0000000000002228

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  10 in total

1.  Comparison between non-visualized polyps and visualized polyps on optical coherence tomography angiography in polypoidal choroidal vasculopathy.

Authors:  Zongyi Zhan; Limei Sun; Chenjin Jin; Yu Yang; Andina Hu; Miao Tang; Zhirong Wang; Xiaoyan Ding
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-08-24       Impact factor: 3.117

Review 2.  Microvascular contributions to age-related macular degeneration (AMD): from mechanisms of choriocapillaris aging to novel interventions.

Authors:  Agnes Lipecz; Lauren Miller; Illes Kovacs; Cecília Czakó; Tamas Csipo; Judit Baffi; Anna Csiszar; Stefano Tarantini; Zoltan Ungvari; Andriy Yabluchanskiy; Shannon Conley
Journal:  Geroscience       Date:  2019-12-04       Impact factor: 7.713

3.  Effects of Induced Astigmatism on Spectral Domain-OCT Angiography Quantitative Metrics.

Authors:  Jesse J Jung; Yu Qiang Soh; Patricia Sha; Sophia Yu; Mary K Durbin; Quan V Hoang
Journal:  Am J Ophthalmol       Date:  2020-07-16       Impact factor: 5.258

4.  Diagnostic Value of Spectral-Domain Optical Coherence Tomography for Polypoidal Choroidal Vasculopathy: A Systematic Review and Meta-Analysis.

Authors:  Yang Jiang; Shixin Qi
Journal:  Front Med (Lausanne)       Date:  2022-06-15

5.  Detection Rate and Diagnostic Value of Optical Coherence Tomography Angiography in the Diagnosis of Polypoidal Choroidal Vasculopathy: A Systematic Review and Meta-Analysis.

Authors:  Yuelin Wang; Jingyuan Yang; Bing Li; Mingzhen Yuan; Youxin Chen
Journal:  J Ophthalmol       Date:  2019-12-14       Impact factor: 1.909

6.  Pachychoroid Neovasculopathy Disguising as Age-Related Macular Degeneration Treated by Spironolactone and Anti-VEGF Combination Therapy.

Authors:  Leonie F Keidel; Benedikt Schworm; Siegfried G Priglinger; Jakob Siedlecki
Journal:  Case Rep Ophthalmol       Date:  2021-04-09

Review 7.  Age-related macular degeneration: Epidemiology, genetics, pathophysiology, diagnosis, and targeted therapy.

Authors:  Yanhui Deng; Lifeng Qiao; Mingyan Du; Chao Qu; Ling Wan; Jie Li; Lulin Huang
Journal:  Genes Dis       Date:  2021-02-27

8.  The Diagnostic Capability of Swept Source OCT Angiography in Treatment-Naive Exudative Neovascular Age-Related Macular Degeneration.

Authors:  Daniel Ahmed; Martin Stattin; Anna-Maria Haas; Stefan Kickinger; Maximilian Gabriel; Alexandra Graf; Katharina Krepler; Siamak Ansari-Shahrezaei
Journal:  J Ophthalmol       Date:  2021-02-16       Impact factor: 1.909

9.  Polypoidal Choroidal Vasculopathy Diagnosis and Neovascular Activity Evaluation Using Optical Coherence Tomography Angiography.

Authors:  Georges Azar; Vivien Vasseur; Corinne Lahoud; Catherine Favard; Flore De Bats; Isabelle Cochereau; Amélie Yachvitz; Martine Mauget-Faÿsse
Journal:  Biomed Res Int       Date:  2021-11-16       Impact factor: 3.411

10.  Diagnosis of Polypoidal Choroidal Vasculopathy From Fluorescein Angiography Using Deep Learning.

Authors:  Yu-Yeh Tsai; Wei-Yang Lin; Shih-Jen Chen; Paisan Ruamviboonsuk; Cheng-Ho King; Chia-Ling Tsai
Journal:  Transl Vis Sci Technol       Date:  2022-02-01       Impact factor: 3.283

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.